NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
July 25, 2026 — Scottsdale Detox coordinates with sister facility The Hope House to close care gaps between detox and rehab, reducing relapse risk. Personalized care with private rooms and executive suites.
July 25, 2026 — Scottsdale TMS Therapy introduces Spravato esketamine nasal spray paired with TMS for treatment-resistant depression, offering fast symptom relief within days. Learn about this innovative clinic.
July 25, 2026 — Arizona IOP launches flexible scheduling for working professionals, allowing device use during recovery. Get intensive outpatient care without career disruption.
July 25, 2026 — The Hope House luxury rehab now verified through Cigna, Aetna, and UMR. Low-density, personalized care in Scottsdale mansions. Call (480) 448-6087.
July 25, 2026 — Foundation for a Drug-Free World engages families at Glendale Cruise Night, distributing Truth About Drugs booklets and inspiring youth pledges. Learn about drug prevention and free e-courses at drugfreeworld.org.
July 25, 2026 — A Georgia dog attack victim seeks compensation with Zagoria Neely Injury Attorneys. Learn about legal rights, responsible pet ownership, and how to pursue damages.
July 25, 2026 — Researchers propose Behçet's spectrum disorders (BSD) framework to classify Behçet-like conditions in children, enabling earlier genetic testing and targeted therapies. Learn about core and peripheral BSD.
July 25, 2026 — Feed Stress Modulators Market projected to grow from $440M in 2026 to $949.9M by 2036 at 8% CAGR. Key players include Kemin, DSM, Cargill. Innovations in phytogenics, probiotics, and precision nutrition drive growth.
July 25, 2026 — Review reveals CHD proteins CHD7, CHD4, CHD8 have distinct roles in heart development, offering new insights into congenital heart defects and improving genetic screening priorities.
July 25, 2026 — Dr. Gina Goldfeder launches LiberaSueña Method in new book 'En un sueño cabe tu vida'. A six-step dream-based approach for personal transformation and healing emotional wounds.
July 24, 2026 — SS Innovations showcases SSi Mantra surgical robot at SRS 2026 with live telesurgery from India, highlighting over 12,000 procedures and 2,100 trained physicians.
July 24, 2026 — VERAXA Biotech appoints Christoph Erkel as CSO to lead BiTAC platform development for solid tumor cancer therapies, advancing bispecific T-cell engagers and ADCs.
July 24, 2026 — Regentis Biomaterials (RGNT) advances GelrinC, a first-in-class cartilage regeneration platform targeting a $3 billion market, offering a 10-minute procedure without cell harvesting. Learn more about this regenerative medicine breakthrough.
July 24, 2026 — Nearly 25% of U.S. employees stay in jobs just to keep health insurance, per Gallup/West Health. BioMedWire reports on job lock and its impact on vulnerable communities. Learn more.
July 24, 2026 — NanoViricides raises $3.8M in registered direct offering to fund NV-387 broad-spectrum antiviral drug development. Lead candidate targets RSV, COVID, Influenza, and MPOX.
July 24, 2026 — Discover the best orthodontists in Harrisburg, NC for braces and Invisalign. NC Tooth Docs tops the list with pediatric dentistry and orthodontic care under one roof.
July 24, 2026 — Winter Springs orthodontist Dr. Jason Battle offers braces and Invisalign with a Lifetime Guarantee at Premiere Orthodontics, ensuring lasting results for patients of all ages.
July 24, 2026 — Premiere Orthodontics in Waterford Lakes, Orlando, offers a Lifetime Guarantee on braces and Invisalign. Board-certified Dr. Jason Battle provides personalized treatment plans with long-term assurance. Learn more about braces in Orlando FL and Invisalign in Orlando FL.
July 24, 2026 — Ireland bans electroshock treatment on minors under new Mental Health Law; CCHR praises move but calls for broader ban. Stop ECT Coalition urges FDA review.
July 23, 2026 — VERAXA Biotech receives Scientific Advice from Germany's Paul-Ehrlich-Institute for its lead BiTAC®-TCE program, advancing its novel cancer therapy platform toward clinical development with reduced uncertainty.